Skip to content

Randomized controlled clinical trial of autologous rib cartilage and iliac bone transplantation for improving talus cartilage injury

Randomized controlled clinical trial of autologous rib cartilage and iliac bone transplantation for improving talus cartilage injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105778
Enrollment
Unknown
Registered
2025-07-10
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury of talus cartilage

Interventions

Experimental group:Autologous rib bone cartilage transplantation
control group:Autologous iliac bone with periosteal bone transplantation

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18-50 with talus cartilage defects, regardless of gender; 2.Hepple stage 5 talus cartilage injury; Cartilage defect range >= 1cm^2; Moderate to severe pain (VAS pain score of 6 or above) accompanied by joint dysfunction and movement disorders; 3.Unilateral talar bone cartilage injury; 4.No severe ligament injuries or severe deformities in the ankle joint; 5.Willing to undergo autologous rib cartilage transplantation surgery or autologous iliac bone transplantation treatment; 6.Non pregnant or lactating women; 7.No history of autoimmune joint disease; 8.Within 6 weeks, there was no infection, surgery, or radiation therapy received in the ankle joint; 9.Voluntarily participate in clinical research and sign informed consent form;

Exclusion criteria

Exclusion criteria: 1.Patients with severe diabetes that affects surgical healing or other internal medical conditions that are unstable and cannot tolerate surgical risks after investigation; 2.Patients with severe rib calcification detected preoperatively; 3.Combined hip and knee joint diseases; 4.Merge ipsilateral ankle arthritis and narrow joint space; 5.Combined osteoporosis (T<-2.5);

Design outcomes

Primary

MeasureTime frame
Foot and Ankle Ability Measure;ICRS score based on the appearance of transplanted cartilage under arthroscopy;

Secondary

MeasureTime frame
Tegner Sports Rating;Ankle joint CT plain scan;Severity score of bone cartilage and cystic talus bone cartilage lesions in the donor area;Visual Analog Scale,VAS;American Orthopaedic Foot and Ankle Association ankle-hindfoot score;Patient satisfaction evaluation of treatment outcomes;Ankle joint MR plain scan;

Countries

China

Contacts

Public ContactWencui Li

Shenzhen Second People's Hospital

13923750767@163.com+86 755 83366388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026